Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
about
Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overviewFunctional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.Immune modulating peptides for the treatment and suppression of multiple sclerosis.Impaired toll-like receptor 8 signaling in multiple sclerosis.Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradationFingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis.Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT.Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.Toll-like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β-Dependent Fibroblast Activation.
P2860
Q27000682-A6BB41CB-37F2-4667-B0E8-81DB127A8ED3Q35095086-84FB8FBB-2EC9-4FE4-96B5-CB16E60A83CCQ36013705-C23A38F5-C2EF-49BC-B12B-AA969A103A1FQ36054671-57C24423-9F49-4942-9082-39D021B24416Q36148314-ECD248D1-CD67-4396-8CBD-B91988F982C4Q36151968-1799EB2D-3638-4ABC-AFD5-0497AC669F88Q36952930-224671DB-BBBD-44F0-8A2F-1D060659DE7FQ37507521-94F49A54-093B-4989-B19C-AB44293C1F0AQ37622730-30AC0F4A-EF3F-4595-89BF-0DE10683DDBAQ38118170-2BE7C199-383E-41B3-80D7-F89E2B10D81DQ39509470-CACE4585-F410-4189-99B2-21DFF3B57EFCQ42264579-1E704087-CF53-41CC-A1BC-24CF927FD4B3Q42708031-941C8C95-CE4E-4ED4-A49C-F3FE33412536Q51688145-F9BA4446-EDEB-4923-A369-022BFE759FC4Q52669033-58EDA4E3-8D69-4FD5-8D84-1B0C26FFDE43
P2860
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
@en
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
@nl
type
label
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
@en
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
@nl
prefLabel
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
@en
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
@nl
P2093
P1476
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
@en
P2093
D Italiano
M Gambuzza
P Bramanti
V Foti Cuzzola
P356
10.1016/J.JNEUROIM.2011.08.010
P577
2011-09-01T00:00:00Z